REFERENCES
- Bunin GR, Surawicz TS, Witman PA. The descriptive epidemiology of craniopharyngioma. J Neurosurg. 1998;89:547–551. [INFOTRIEVE], [CSA]
- Adamson TE, Wiestler OD, Kleihues P. Correlation of clinical and pathological features in surgically treated craniopharyngiomas. J Neurosurg. 1990;73:12–17. [INFOTRIEVE], [CSA]
- Tabbador K, Shulman K, Dal Canto M. Neonatal craniopharyngioma. Am J Dis Children. 1974;128:381–383. [CSA]
- Crotty TB, Scheithauer BW, Young WF, , et al. Papillary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg. 1995;83:206–214. [INFOTRIEVE], [CSA]
- Sartoretti-Schefer S, Wichmann W, Aguzzi A. MR differentiation of adamantinomatous and squamous-papillary craniopharyngiomas. Am J Neuradiol. 1997;18:77–87. [CSA]
- Thapar K, Kovacs K. Neoplasms of the sellar region. In: Bigner DD, McLendon RE, Bruner J, eds. Russell and Rubinstein's Pathology of Tumors of the Nervous System, ed 6. London: Arnold; 1998; 561–677.
- Giangaspero F, Burger PC, Osborne DR. Suprasellar papillary squamous epitelioma (“papillary craniopharyngioma”). Am J Surg Pathol. 1984;8:57–64. [INFOTRIEVE], [CSA]
- Kleihues P, Cavenee WK. Pathology and Genetics of Tumors of the Nervous System. Lyon: IARC; 2000.
- Seung-Ki K, Kyu-Chang W, Sang-Hoon S. Radical excision of pediatric craniopharyngioma: recurrence pattern and prognostic factors. Child's Nerv Syst. 2001;17:531–536. [CSA], [CROSSREF]
- Sanford RA. Craniopharyngioma: results of survey of the American Society of Pediatric Neurosurgery. Pediatr Neurosurg. 1994;21:39–43. [INFOTRIEVE], [CSA]
- Weiner HL, Wisoff JH, Rosenberg ME, , et al. Craniopharyngiomas: a clinico-pathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery. 1994;35:1001–1010. [INFOTRIEVE], [CSA]
- Yasargil MG, Curcic M, Kis M. Total removal of craniopharyngiomas: approaches and long-term results in 144 patients. J Neurosurg. 1990;73:3–11. [INFOTRIEVE], [CSA]
- Barua KK, Ehara K, Kohmura E, Tamaki N. Treatment of recurrent craniopharyngiomas. Kobe J Med Sci. 2003;49:123–132. [INFOTRIEVE], [CSA]
- Caldarelli M, Di Rocco C, Papacci F. Management of recurrent craniopharyngioma. Acta Neurochir. 1998;140:447–454. [CSA], [CROSSREF]
- Nishi T, Kuratsu J, Takeshima H. Prognostic significance of the MIB-1 labeling index for patient with craniopharyngioma. Int J Mol Med. 1999;3:157–161. [INFOTRIEVE], [CSA]
- Kim SK, Wang KC, Shin SH, Choe G, Chi JG, Cho BK. Radical excision of pediatric craniopharyngioma: recurrence pattern and prognostic factors. Childs Nerv Syst. 2001;17:531–536; discussion, 537. [INFOTRIEVE], [CSA], [CROSSREF]
- Duo D, Gasverde S, Benech F, Zenga F, Giordana MT. MIB-1 immunoreactivity in craniopharyngiomas: a clinico-pathological analysis. Clin Neuropathol. 2003;22:229–234. [INFOTRIEVE], [CSA]
- Losa M, Vimercati A, Acerno S, , et al. Correlation between clinical characteristics and proliferative activity in patients with craniopharyngioma. J Neurol Neurosurg Psychiatry. 2004;75:889–892. [INFOTRIEVE], [CSA], [CROSSREF]
- Roberts WG, Palade GE. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res. 1997;57:765–772. [INFOTRIEVE], [CSA]
- Vidal S, Kovacs K, Lloyd RV, Meyer FB, Scheithauer BW. Angiogenesis in patients with craniopharingiomas: correlation with treatment and outcome. Cancer. 2002;94:738–745. [INFOTRIEVE], [CSA], [CROSSREF]
- Liszczak T, Richardson EP Jr, Phillips JP, Jacobson S, Kornblith PL. Morphological, biochemical, ultrastructural, tissue culture and clinical observation of typical and aggressive craniopharyngiomas. Acta Neuropathol. 1978;43:191–203. [INFOTRIEVE], [CSA]
- Szeifert GT, Julow J, Szabolcs M, Slowik F, Balint K, Pasztor E. Secretory component of cystic craniopharyngiomas: a mucino-histochemical and electron-microscopic study. Surg Neurol. 1991;36:286–293. [INFOTRIEVE], [CSA], [CROSSREF]
- Diaz-Flores L, Gutierrez R, Varela H. Angiogenesis: an update. Histol Histopathol. 1994;9:807–843. [INFOTRIEVE], [CSA]
- Hirano A, Matsui T. Vascular structures in brain tumors. Hum Pathol. 1975;6:611–621. [INFOTRIEVE], [CSA]
- Shibata S. Ultrastructure of capillary walls in human brain tumors. Acta Neuropathol (Berl). 1989;78:561–571. [CSA], [CROSSREF]
- Eldevik OP, Blaivas M, Gabrielsen TO. Craniopharyngioma: radiologic and histologic findings and recurrence. Am J Neuroradiol. 1996;17:1427–1439. [INFOTRIEVE], [CSA]
- Dinda AK, Kharbanda K, Sarkar C. In vivo proliferative potential of primary human brain tumors; its correlation with histological classification and morphological features, II: nonglial tumors. Pathology. 1993;25:10–14. [INFOTRIEVE], [CSA]
- Broggi G, Franzini A, Cajola L. Cell kinetic investigations in craniopharyngioma: preliminary results and considerations. Pediatr Neurosurg. 1994;21:21–23. [INFOTRIEVE], [CSA]
- Uematsu Y, Komai N, Tanaka Y, , et al. Cellular differentation, secretory and proliferative activities of craniopharyngiomas. Noshuyo Byori. 1994;11:43–50. [INFOTRIEVE], [CSA]
- Honegger J, Renner C, Fahlbusch R. Progesterone receptor gene expression in craniopharyngiomas and evidence for biological activity. Neurosurgery. 1997;41:1359–1363. [INFOTRIEVE], [CSA], [CROSSREF]
- Anegawa S, Hayashi T, Nakagawa S. Craniopharyngioma with rapid regrowth-role of MIB-1 labeling index. No Shinkei Geka. 2001;29:727–733. [INFOTRIEVE], [CSA]
- Raghavan R, Dickey WT Jr, Margraf LR, , et al. Proliferative activity in craniopharyngiomas: clinicopathological correlations in adult and children. Surg Neurol. 2000;54:241–247. [INFOTRIEVE], [CSA], [CROSSREF]
- Dickey T, Raghaven R, Rushing E. MIB-1 (Ki-67) immunoreactivity as predictor of the risk of recurrence of craniopharyngiomas. J Neuropathol Exp Neurol. 1999;58:567. [CSA]
- Tsunenari I, Yamate J, Iwaki M, Kuwamura M, Kotani T, Sakuma S. Angioarchitecture of tumors induced by two different cloned cell lines established from a transplantable rat malignant fibrous histiocytoma. Microsc Microanal. 2003;9:532–541. [INFOTRIEVE], [CSA]
- McLone DG. Ultrastructure of the vasculature of central nervous system tumors of childhood. Childs Brain. 1980;6:242–254. [INFOTRIEVE], [CSA]
- Deane BR, Lantos PL. The vasculature of experimental brain tumors, 2: quantitative assessment of morphological abnormalities. J Neurol Sci. 1981;49:67–77. [INFOTRIEVE], [CSA], [CROSSREF]
- Uematsu Y, Hirano A, Llena JF. Electron microscopic observations of blood vessels in ependymoma. No Shinkei Geka. 1988;16:1235–1242. [INFOTRIEVE], [CSA]
- Roy S, Sarkar C. Ultrastructural study of micro-blood vessels in human brain tumors and peritumoral tissue. J Neurooncol. 1989;7:283–292. [INFOTRIEVE], [CSA], [CROSSREF]
- Elmaci L, Kurtkaya-Yapicier O, Ekinci G, , et al. Metastatic papillary craniopharyngioma: case study and study of tumor angiogenesis. Neuro-oncology. 2002;4:123–128. [INFOTRIEVE], [CSA], [CROSSREF]
- Vilches J, Lopez A, Martinez MC, Gomez J, Barbera J. Scannino and transmission electron microscopy of craniopharyngioma: x-ray microanalytical study of the intratumoral mineralized deposits. Ultrastruct Pathol. 1981;2:343–356. [INFOTRIEVE], [CSA]
- Oka H, Kawano N, Yagishita S, Kobayashi I, Saegusa H, Fujii K. Origin of ciliated craniopharyngioma: pathological relationship between Rathke cleft cyst and ciliated craniopharyngioma. Noshuyo Byori. 1995;12:97–103. [INFOTRIEVE], [CSA]
- Oka H, Kawano N, Yagishita S, Kobayashi I, Saegusa H, Fujii K. Ciliated craniopharyngioma indicates histogenetic relationship to Rathke cleft epithelium. Clin Neuropathol. 1997;16:103–106. [INFOTRIEVE], [CSA]
- Sato K, Kubota T. Fine structure of ossification in craniopharyngiomas. Ultrastruct Pathol. 1999;23:395–399. [INFOTRIEVE], [CSA], [CROSSREF]